|
Newsletters, Reports and Journal Articles
Return to National MIRECC Products Page
Newsletters | Reports | Journal Articles
Newsletters
- National MIRECC Education Group Newsletter
- This biennial hard copy newsletter features education, research, and clinical news from the eight MIRECCs. This newsletter requires Adobe Acrobat Reader.
Contact:Michael.Kauth@med.va.gov to receive a printed copy
- Volume 1, Issue 1
- Volume 2, Issue 1
- Volume 2, Issue 2
- Volume 3, Issue 1
- Volume 3, Issue 2
- Volume 4, Issue 1
- Volume 4, Issue 2 Pages 1,2,5 & 6 | Insert Pages 3 & 4
- Volume 5, Issue 1
- Volume 5, Issue 2
- Volume 6, Issue 1
- Volume 6, Issue 2
- Volume 7, Issue 1
- Volume 7, Issue 2
- Volume 8, Issue 1
|
- South Central MIRECC Communiqué.
- Description: This monthly electronic newsletter is published monthly and features education, research, and clinical news sponsored by the South Central (VISN 16) MIRECC.
- Read archived articles online at: http://www.va.gov/scmirecc/page.cfm?pg=14
Contact: Michael.Kauth@va.gov to subscribe.
Host: South Central (VISN 16) MIRECC
|
- MindView Newsletter
- Printed and On-Line Consumer Oriented Newsletter Articles
http://www.desertpacific.mirecc.va.gov/mindview.shtml
Contact: Louise Mahoney at Louise.Mahoney@va.gov or subscribe online at http://www.desertpacific.mirecc.va.gov/subscribe.html Host MIRECC: VA Desert Pacific Healthcare Network (VISN 22)
Day Treatment Center: Togetherness, Acceptance & Respect
Description: A collection of eight psychoeducational newsletters for veterans with chronic mental illness, including schizophrenia and related disorders.
Contact: Michael.Kauth@va.gov
Host: South Central (VISN 16) MIRECC
|
Reports
Product: Brief Research Reports
Description: These one-page articles summarize key findings from VISN 1 MIRECC Sponsored Research. Full versions of research articles available on request.
Contact: Bruce.Rounsaville@yale.edu
Host: VISN 1 MIRECC |
Product: Consensus Statement on Clinical Practice
Title: MIRECC/VA Task Force Policy Review of the Naltrexone for Alcoholism
Description: This article provides recommendations on use of naltrexone for alcoholism within the VA system based on recently emerging reports on efficacy of naltrexone for veterans with alcohol dependence.
Contact: Bruce.Rounsaville@yale.edu
Host: VA New England Healthcare System (VISN 1) MIRECC
|
Title: HIV Medication Adherence Tool Kit: An Educational Intervention (Michael Kauth, Ph.D., and Trevor Hart, Ph.D, New Orleans VAMC).
Description: This report describes a brief educational intervention using pillboxes with HIV-seropositive veterans.
Level of evaluation: Pre-post comparison of adherence rates.
Contact: Michael.Kauth@med.va.gov.
Host: South Central (VISN 16) MIRECC
|
Product: Consensus Statement on Clinical Practice
Title: MIRECC/VA Task Force Policy Review of the Naltrexone for Alcoholism
Description: This article provides recommendations on use of naltrexone for alcoholism within the VA system based on recently emerging reports on efficacy of naltrexone for veterans with alcohol dependence.
Contact: Bruce.Rounsaville@yale.edu
Host MIRECC: New England (VISN 1)
|
Journal Articles
Product: Email Journal
Title:NCPTSD Science-into-Practice
Description: A quarterly email journal that summarizes latest clinically relevant research in the area of PTSD. A quick way to stay up on the literature.
Contact: Robyn.Walser@va.gov for subscription
Host MIRECC: VA Sierra Pacific Healthcare Network (VISN 21)
|
Product: Journal Article
Title: Set of Core Clinical Competencies for Providing Care to Individuals With Severe Mental Illness.Young AS, Forquer SL, Tran A, Starzynski M, Shatkin J., Identifying clinical competencies that support rehabilitation and empowerment in individuals with severe mental illness. Journal of Behavioral Health Services & Research. 2000;27:321-333.
Contact: Alexander Young, M.D., M.S.H.S. at (310) 268-3647
Link to the set of Core competencies
Host MIRECC: VA Desert Pacific Healthcare Network
|
Product: Methodological Research Articles and Research Review Articles
Description: Articles presenting reviews of psychotherapy research, substance abuse research and practice guidelines.
Contact: http://info.med.yale.edu/psych/research/psychotherapy/
Host MIRECC: New England (VISN 1) |
Product: Article
Title: Review Paper on Behavior Management with Gabapentin
Description: A Retrospective Chart Review of Gabapentin for the Treatment of Aggressive and Agitated Behavior in Patients with Dementias
Contact: James Hawkins, M.D. and Associates
Host MIRECC: VA Sierra Pacific Healthcare Network (VISN 21)
|
Product: Journal Article
Title: A Multicultural Developmental Approach for Treating Trauma
Fred Gusman, M.S.W., and Associates
Contact: Robyn.Walser@va.gov
Host MIRECC: VA Sierra Pacific Healthcare Network (VISN 21)
|
Product: Review Article
Title: Assessment and Treatment of Concurrent Posttraumatic Stress Disorder and Substance Abuse By Josef I. Ruzek
Contact: Josef.Ruzek@va.gov
Host MIRECC: VA Sierra Pacific Healthcare Network (VISN 21)
|
Product: Journal article.
Title: Molinari, V., Kier, F.J., & Kunik, M.E. (2001). Obtaining age-related mental health competency: What is needed? Educational Gerontology, 28, 1-10.
Description: This article describes a survey of mental health professionals in the South Central VA Healthcare Network (VISN 16) regarding competency to address the mental health needs of older veterans.
Contact: Michael.Kauth@va.gov
Host: South Central (VISN 16) MIRECC
|
Product: Journal article.
Title: Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. Journal of Neuroscience Volume 26 (24) 6583-6588, 2006.
Description: This article -- a collaborative effort between the VISN 4 MIRECC Neuroimaging Core, the NIDA Intramural Program and Brookhaven Laboratories -- is the first demonstration that dopamine release occurs during cue-induced cocaine craving in humans. This finding is a critical proof-of-concept for guiding medication
development, and has immediate translational implications, as medications that modulate dopamine (such as the GABAergics) would be expected to have particular clinical benefit. In VISN 4 MIRECC, we are thus testing the GABA B agonist baclofen, and it indeed shows promise in blunting both drug craving and the brain response to drug cues.
Contact: Anna Rose Childress
Host: Stars and Stripes Healthcare Network (VISN 4) MIRECC
|
|
